The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

Another option for small, low-risk lesions is topical chemotherapy ... you apply this cream or lotion at home for three to six weeks. Your skin may become irritated and red during treatment with 5-FU.

Figuring how to get rid of textured skin is the best place to start. If your skin is full of highs and lows (literally), ...

Hand, foot and mouth disease (HFMD) is a very common viral infection that predominantly affects children under the age of 5, ...

Hidradenitis suppurativa (HS) is an immune disease that affects up to 4% of the global population and causes painful, recurring skin lesions and inflammation, primarily in the folds of the skin.

Researchers Develop Nanofiber Patch for Treatment of Psoriasis Nov. 12 ... which was trained on data from 53,601 skin lesions from 25,105 patients, outperforming existing ...

Kaposi’s sarcoma usually appears as lesions on the skin or on mucosal surfaces (like inside the mouth or genitals). HIV treatment protects against Kaposi’s sarcoma and slows down disease progression.

This could include checking for skin lesions that could indicate a herpes simplex virus infection or symptoms such as a cough that might mean you have pneumonia. Most of the time, erythema ...

An 82-year-old male patient presented with an approximately 2-year history of a pruritic, eczema-like skin lesion (Figure). Topical therapies initiated elsewhere with different antiseptics ...

Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...